 | • レポートコード：QAF27582 • 出版社/出版日：QYResearch / 2021年4月7日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の細菌性膣炎治療薬市場について種類別（Rx、OTC）、用途別（病院、薬局、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・細菌性膣炎治療薬市場の概要 ・世界の主要地域別細菌性膣炎治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の細菌性膣炎治療薬市場規模2016-2021：種類別（Rx、OTC） ・世界の細菌性膣炎治療薬市場予測2012-2027：種類別（Rx、OTC） ・世界の細菌性膣炎治療薬市場規模2016-2021：用途別（病院、薬局、その他） ・世界の細菌性膣炎治療薬市場予測2012-2027：用途別（病院、薬局、その他） ・細菌性膣炎治療薬のアメリカ市場規模と予測2016-2021 ・細菌性膣炎治療薬のヨーロッパ市場規模と予測2016-2021 ・細菌性膣炎治療薬の中国市場規模と予測2016-2021 ・細菌性膣炎治療薬の日本市場規模と予測2016-2021 ・細菌性膣炎治療薬の東南アジア市場規模と予測2016-2021 ・細菌性膣炎治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bayer、Pfizer、Sanofi、Piramal、Abbott、Galderma、Mission、Alkem、Xiuzheng、Teva、Perrigo、West-Ward、HPGC、Yunnan Baiyao、Starpharma、Novel、Edenvridge） ・細菌性膣炎治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・細菌性膣炎治療薬の市場動向・機会・課題 ・調査の結論 |
Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 2016 is about 72%.
Bacterial vaginosis drug is widely sold in hospital, pharmacy and other field. The most proportion of bacterial vaginosis drug is sold in pharmacy, and the revenue in 2016 is about 423 M USD.
USA region is the largest supplier of bacterial vaginosis drug, with a revenue market share nearly 32% in 2016. Europe is the second largest supplier of Bacterial Vaginosis Drug, enjoying revenue market share nearly 30% in 2016.
USA and Europe are the largest consumption places, with the consumption market share nearly 28% in 2016.
Market competition is intense. Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Bacterial Vaginosis Drug Market
The global Bacterial Vaginosis Drug market was valued at US$ 916.5 in 2020 and will reach US$ 1107.1 million by the end of 2027, growing at a CAGR of 3.2% during 2022-2027.
Global Bacterial Vaginosis Drug Scope and Market Size
The global Bacterial Vaginosis Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Rx
OTC
Segment by Application
Hospital
Pharmacy
Other
The Bacterial Vaginosis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Bacterial Vaginosis Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
1 Bacterial Vaginosis Drug Market Overview
1.1 Bacterial Vaginosis Drug Product Scope
1.2 Bacterial Vaginosis Drug Segment by Type
1.2.1 Global Bacterial Vaginosis Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Rx
1.2.3 OTC
1.3 Bacterial Vaginosis Drug Segment by Application
1.3.1 Global Bacterial Vaginosis Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Bacterial Vaginosis Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bacterial Vaginosis Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bacterial Vaginosis Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bacterial Vaginosis Drug Price Trends (2016-2027)
2 Bacterial Vaginosis Drug Estimates and Forecasts by Region
2.1 Global Bacterial Vaginosis Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bacterial Vaginosis Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bacterial Vaginosis Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Bacterial Vaginosis Drug Revenue Market Share by Region (2016-2021)
2.3 Global Bacterial Vaginosis Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bacterial Vaginosis Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bacterial Vaginosis Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bacterial Vaginosis Drug Estimates and Projections (2016-2027)
2.4.2 Europe Bacterial Vaginosis Drug Estimates and Projections (2016-2027)
2.4.3 China Bacterial Vaginosis Drug Estimates and Projections (2016-2027)
2.4.4 Japan Bacterial Vaginosis Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bacterial Vaginosis Drug Estimates and Projections (2016-2027)
2.4.6 India Bacterial Vaginosis Drug Estimates and Projections (2016-2027)
3 Global Bacterial Vaginosis Drug Competition Landscape by Players
3.1 Global Top Bacterial Vaginosis Drug Players by Sales (2016-2021)
3.2 Global Top Bacterial Vaginosis Drug Players by Revenue (2016-2021)
3.3 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bacterial Vaginosis Drug as of 2020)
3.4 Global Bacterial Vaginosis Drug Average Price by Company (2016-2021)
3.5 Manufacturers Bacterial Vaginosis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Bacterial Vaginosis Drug Market Size by Type
4.1 Global Bacterial Vaginosis Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Bacterial Vaginosis Drug Price by Type (2016-2021)
4.2 Global Bacterial Vaginosis Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bacterial Vaginosis Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Bacterial Vaginosis Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Bacterial Vaginosis Drug Price Forecast by Type (2022-2027)
5 Global Bacterial Vaginosis Drug Market Size by Application
5.1 Global Bacterial Vaginosis Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Bacterial Vaginosis Drug Price by Application (2016-2021)
5.2 Global Bacterial Vaginosis Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bacterial Vaginosis Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Bacterial Vaginosis Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Bacterial Vaginosis Drug Price Forecast by Application (2022-2027)
6 North America Bacterial Vaginosis Drug Market Facts & Figures
6.1 North America Bacterial Vaginosis Drug Sales by Company
6.1.1 North America Bacterial Vaginosis Drug Sales by Company (2016-2021)
6.1.2 North America Bacterial Vaginosis Drug Revenue by Company (2016-2021)
6.2 North America Bacterial Vaginosis Drug Sales Breakdown by Type
6.2.1 North America Bacterial Vaginosis Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Bacterial Vaginosis Drug Sales Breakdown by Type (2022-2027)
6.3 North America Bacterial Vaginosis Drug Sales Breakdown by Application
6.3.1 North America Bacterial Vaginosis Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Bacterial Vaginosis Drug Sales Breakdown by Application (2022-2027)
7 Europe Bacterial Vaginosis Drug Market Facts & Figures
7.1 Europe Bacterial Vaginosis Drug Sales by Company
7.1.1 Europe Bacterial Vaginosis Drug Sales by Company (2016-2021)
7.1.2 Europe Bacterial Vaginosis Drug Revenue by Company (2016-2021)
7.2 Europe Bacterial Vaginosis Drug Sales Breakdown by Type
7.2.1 Europe Bacterial Vaginosis Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bacterial Vaginosis Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Bacterial Vaginosis Drug Sales Breakdown by Application
7.3.1 Europe 148 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 148 Sales Breakdown by Application (2022-2027)
8 China Bacterial Vaginosis Drug Market Facts & Figures
8.1 China Bacterial Vaginosis Drug Sales by Company
8.1.1 China Bacterial Vaginosis Drug Sales by Company (2016-2021)
8.1.2 China Bacterial Vaginosis Drug Revenue by Company (2016-2021)
8.2 China Bacterial Vaginosis Drug Sales Breakdown by Type
8.2.1 China Bacterial Vaginosis Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Bacterial Vaginosis Drug Sales Breakdown by Type (2022-2027)
8.3 China Bacterial Vaginosis Drug Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Bacterial Vaginosis Drug Market Facts & Figures
9.1 Japan Bacterial Vaginosis Drug Sales by Company
9.1.1 Japan Bacterial Vaginosis Drug Sales by Company (2016-2021)
9.1.2 Japan Bacterial Vaginosis Drug Revenue by Company (2016-2021)
9.2 Japan Bacterial Vaginosis Drug Sales Breakdown by Type
9.2.1 Japan Bacterial Vaginosis Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bacterial Vaginosis Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Bacterial Vaginosis Drug Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Bacterial Vaginosis Drug Market Facts & Figures
10.1 Southeast Asia Bacterial Vaginosis Drug Sales by Company
10.1.1 Southeast Asia Bacterial Vaginosis Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Bacterial Vaginosis Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Bacterial Vaginosis Drug Sales Breakdown by Type
10.2.1 Southeast Asia Bacterial Vaginosis Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bacterial Vaginosis Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bacterial Vaginosis Drug Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Bacterial Vaginosis Drug Market Facts & Figures
11.1 India Bacterial Vaginosis Drug Sales by Company
11.1.1 India Bacterial Vaginosis Drug Sales by Company (2016-2021)
11.1.2 India Bacterial Vaginosis Drug Revenue by Company (2016-2021)
11.2 India Bacterial Vaginosis Drug Sales Breakdown by Type
11.2.1 India Bacterial Vaginosis Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Bacterial Vaginosis Drug Sales Breakdown by Type (2022-2027)
11.3 India Bacterial Vaginosis Drug Sales Breakdown by Application
11.3.1 India Bacterial Vaginosis Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Bacterial Vaginosis Drug Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Bacterial Vaginosis Drug Business
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Business Overview
12.1.3 Bayer Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bayer Bacterial Vaginosis Drug Products Offered
12.1.5 Bayer Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Bacterial Vaginosis Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Bacterial Vaginosis Drug Products Offered
12.3.5 Sanofi Recent Development
12.4 Piramal
12.4.1 Piramal Corporation Information
12.4.2 Piramal Business Overview
12.4.3 Piramal Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Piramal Bacterial Vaginosis Drug Products Offered
12.4.5 Piramal Recent Development
12.5 Abbott
12.5.1 Abbott Corporation Information
12.5.2 Abbott Business Overview
12.5.3 Abbott Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Abbott Bacterial Vaginosis Drug Products Offered
12.5.5 Abbott Recent Development
12.6 Galderma
12.6.1 Galderma Corporation Information
12.6.2 Galderma Business Overview
12.6.3 Galderma Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Galderma Bacterial Vaginosis Drug Products Offered
12.6.5 Galderma Recent Development
12.7 Mission
12.7.1 Mission Corporation Information
12.7.2 Mission Business Overview
12.7.3 Mission Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mission Bacterial Vaginosis Drug Products Offered
12.7.5 Mission Recent Development
12.8 Alkem
12.8.1 Alkem Corporation Information
12.8.2 Alkem Business Overview
12.8.3 Alkem Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Alkem Bacterial Vaginosis Drug Products Offered
12.8.5 Alkem Recent Development
12.9 Xiuzheng
12.9.1 Xiuzheng Corporation Information
12.9.2 Xiuzheng Business Overview
12.9.3 Xiuzheng Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Xiuzheng Bacterial Vaginosis Drug Products Offered
12.9.5 Xiuzheng Recent Development
12.10 Teva
12.10.1 Teva Corporation Information
12.10.2 Teva Business Overview
12.10.3 Teva Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Bacterial Vaginosis Drug Products Offered
12.10.5 Teva Recent Development
12.11 Perrigo
12.11.1 Perrigo Corporation Information
12.11.2 Perrigo Business Overview
12.11.3 Perrigo Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Perrigo Bacterial Vaginosis Drug Products Offered
12.11.5 Perrigo Recent Development
12.12 West-Ward
12.12.1 West-Ward Corporation Information
12.12.2 West-Ward Business Overview
12.12.3 West-Ward Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 West-Ward Bacterial Vaginosis Drug Products Offered
12.12.5 West-Ward Recent Development
12.13 HPGC
12.13.1 HPGC Corporation Information
12.13.2 HPGC Business Overview
12.13.3 HPGC Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 HPGC Bacterial Vaginosis Drug Products Offered
12.13.5 HPGC Recent Development
12.14 Yunnan Baiyao
12.14.1 Yunnan Baiyao Corporation Information
12.14.2 Yunnan Baiyao Business Overview
12.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Yunnan Baiyao Bacterial Vaginosis Drug Products Offered
12.14.5 Yunnan Baiyao Recent Development
12.15 Starpharma
12.15.1 Starpharma Corporation Information
12.15.2 Starpharma Business Overview
12.15.3 Starpharma Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Starpharma Bacterial Vaginosis Drug Products Offered
12.15.5 Starpharma Recent Development
12.16 Novel
12.16.1 Novel Corporation Information
12.16.2 Novel Business Overview
12.16.3 Novel Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Novel Bacterial Vaginosis Drug Products Offered
12.16.5 Novel Recent Development
12.17 Edenvridge
12.17.1 Edenvridge Corporation Information
12.17.2 Edenvridge Business Overview
12.17.3 Edenvridge Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Edenvridge Bacterial Vaginosis Drug Products Offered
12.17.5 Edenvridge Recent Development
13 Bacterial Vaginosis Drug Manufacturing Cost Analysis
13.1 Bacterial Vaginosis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bacterial Vaginosis Drug
13.4 Bacterial Vaginosis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bacterial Vaginosis Drug Distributors List
14.3 Bacterial Vaginosis Drug Customers
15 Market Dynamics
15.1 Bacterial Vaginosis Drug Market Trends
15.2 Bacterial Vaginosis Drug Drivers
15.3 Bacterial Vaginosis Drug Market Challenges
15.4 Bacterial Vaginosis Drug Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bacterial Vaginosis Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bacterial Vaginosis Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bacterial Vaginosis Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bacterial Vaginosis Drug Sales (K MT) by Region (2016-2021)
Table 5. Global Bacterial Vaginosis Drug Sales Market Share by Region (2016-2021)
Table 6. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bacterial Vaginosis Drug Revenue Share by Region (2016-2021)
Table 8. Global Bacterial Vaginosis Drug Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Bacterial Vaginosis Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bacterial Vaginosis Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bacterial Vaginosis Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bacterial Vaginosis Drug Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Bacterial Vaginosis Drug Sales Share by Company (2016-2021)
Table 14. Global Bacterial Vaginosis Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bacterial Vaginosis Drug Revenue Share by Company (2016-2021)
Table 16. Global Bacterial Vaginosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2020)
Table 17. Global Bacterial Vaginosis Drug Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Bacterial Vaginosis Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Bacterial Vaginosis Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bacterial Vaginosis Drug Sales (K MT) by Type (2016-2021)
Table 22. Global Bacterial Vaginosis Drug Sales Share by Type (2016-2021)
Table 23. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bacterial Vaginosis Drug Price (USD/MT) by Type (2016-2021)
Table 25. Global Bacterial Vaginosis Drug Sales Share by Type (2022-2027)
Table 26. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bacterial Vaginosis Drug Revenue Share by Type (2022-2027)
Table 28. Global Bacterial Vaginosis Drug Price (USD/MT) by Type (2022-2027)
Table 29. Global Bacterial Vaginosis Drug Sales (K MT) by Application (2016-2021)
Table 30. Global Bacterial Vaginosis Drug Sales Share by Application (2016-2021)
Table 31. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bacterial Vaginosis Drug Price (USD/MT) by Application (2016-2021)
Table 33. Global Bacterial Vaginosis Drug Sales (K MT) by Application (2022-2027)
Table 34. Global Bacterial Vaginosis Drug Sales Share by Application (2022-2027)
Table 35. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bacterial Vaginosis Drug Revenue Share by Application (2022-2027)
Table 37. Global Bacterial Vaginosis Drug Price (USD/MT) by Application (2022-2027)
Table 38. North America Bacterial Vaginosis Drug Sales (K MT) by Company (2016-2021)
Table 39. North America Bacterial Vaginosis Drug Sales Market Share by Company (2016-2021)
Table 40. North America Bacterial Vaginosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bacterial Vaginosis Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Bacterial Vaginosis Drug Sales by Type (2016-2021) & (K MT)
Table 43. North America Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
Table 44. North America Bacterial Vaginosis Drug Sales by Type (2022-2027) & (K MT)
Table 45. North America Bacterial Vaginosis Drug Sales Market Share by Type (2022-2027)
Table 46. North America Bacterial Vaginosis Drug Sales by Application (2016-2021) & (K MT)
Table 47. North America Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
Table 48. North America Bacterial Vaginosis Drug Sales by Application (2022-2027) & (K MT)
Table 49. North America Bacterial Vaginosis Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Bacterial Vaginosis Drug Sales (K MT) by Company (2016-2021)
Table 51. Europe Bacterial Vaginosis Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Bacterial Vaginosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bacterial Vaginosis Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Bacterial Vaginosis Drug Sales by Type (2016-2021) & (K MT)
Table 55. Europe Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Bacterial Vaginosis Drug Sales by Type (2022-2027) & (K MT)
Table 57. Europe Bacterial Vaginosis Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Bacterial Vaginosis Drug Sales by Application (2016-2021) & (K MT)
Table 59. Europe Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Bacterial Vaginosis Drug Sales by Application (2022-2027) & (K MT)
Table 61. Europe Bacterial Vaginosis Drug Sales Market Share by Application (2022-2027)
Table 62. China Bacterial Vaginosis Drug Sales (K MT) by Company (2016-2021)
Table 63. China Bacterial Vaginosis Drug Sales Market Share by Company (2016-2021)
Table 64. China Bacterial Vaginosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bacterial Vaginosis Drug Revenue Market Share by Company (2016-2021)
Table 66. China Bacterial Vaginosis Drug Sales by Type (2016-2021) & (K MT)
Table 67. China Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
Table 68. China Bacterial Vaginosis Drug Sales by Type (2022-2027) & (K MT)
Table 69. China Bacterial Vaginosis Drug Sales Market Share by Type (2022-2027)
Table 70. China Bacterial Vaginosis Drug Sales by Application (2016-2021) & (K MT)
Table 71. China Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
Table 72. China Bacterial Vaginosis Drug Sales by Application (2022-2027) & (K MT)
Table 73. China Bacterial Vaginosis Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Bacterial Vaginosis Drug Sales (K MT) by Company (2016-2021)
Table 75. Japan Bacterial Vaginosis Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Bacterial Vaginosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bacterial Vaginosis Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Bacterial Vaginosis Drug Sales by Type (2016-2021) & (K MT)
Table 79. Japan Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Bacterial Vaginosis Drug Sales by Type (2022-2027) & (K MT)
Table 81. Japan Bacterial Vaginosis Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Bacterial Vaginosis Drug Sales by Application (2016-2021) & (K MT)
Table 83. Japan Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Bacterial Vaginosis Drug Sales by Application (2022-2027) & (K MT)
Table 85. Japan Bacterial Vaginosis Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bacterial Vaginosis Drug Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bacterial Vaginosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bacterial Vaginosis Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bacterial Vaginosis Drug Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bacterial Vaginosis Drug Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bacterial Vaginosis Drug Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bacterial Vaginosis Drug Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Application (2022-2027)
Table 98. India Bacterial Vaginosis Drug Sales (K MT) by Company (2016-2021)
Table 99. India Bacterial Vaginosis Drug Sales Market Share by Company (2016-2021)
Table 100. India Bacterial Vaginosis Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bacterial Vaginosis Drug Revenue Market Share by Company (2016-2021)
Table 102. India Bacterial Vaginosis Drug Sales by Type (2016-2021) & (K MT)
Table 103. India Bacterial Vaginosis Drug Sales Market Share by Type (2016-2021)
Table 104. India Bacterial Vaginosis Drug Sales by Type (2022-2027) & (K MT)
Table 105. India Bacterial Vaginosis Drug Sales Market Share by Type (2022-2027)
Table 106. India Bacterial Vaginosis Drug Sales by Application (2016-2021) & (K MT)
Table 107. India Bacterial Vaginosis Drug Sales Market Share by Application (2016-2021)
Table 108. India Bacterial Vaginosis Drug Sales by Application (2022-2027) & (K MT)
Table 109. India Bacterial Vaginosis Drug Sales Market Share by Application (2022-2027)
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Bayer Bacterial Vaginosis Drug Product
Table 114. Bayer Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. Pfizer Bacterial Vaginosis Drug Product
Table 119. Pfizer Recent Development
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Sanofi Bacterial Vaginosis Drug Product
Table 124. Sanofi Recent Development
Table 125. Piramal Corporation Information
Table 126. Piramal Description and Business Overview
Table 127. Piramal Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Piramal Bacterial Vaginosis Drug Product
Table 129. Piramal Recent Development
Table 130. Abbott Corporation Information
Table 131. Abbott Description and Business Overview
Table 132. Abbott Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. Abbott Bacterial Vaginosis Drug Product
Table 134. Abbott Recent Development
Table 135. Galderma Corporation Information
Table 136. Galderma Description and Business Overview
Table 137. Galderma Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Galderma Bacterial Vaginosis Drug Product
Table 139. Galderma Recent Development
Table 140. Mission Corporation Information
Table 141. Mission Description and Business Overview
Table 142. Mission Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Mission Bacterial Vaginosis Drug Product
Table 144. Mission Recent Development
Table 145. Alkem Corporation Information
Table 146. Alkem Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Alkem Description and Business Overview
Table 148. Alkem Bacterial Vaginosis Drug Product
Table 149. Alkem Recent Development
Table 150. Xiuzheng Corporation Information
Table 151. Xiuzheng Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Xiuzheng Description and Business Overview
Table 153. Xiuzheng Bacterial Vaginosis Drug Product
Table 154. Xiuzheng Recent Development
Table 155. Teva Corporation Information
Table 156. Teva Description and Business Overview
Table 157. Teva Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Teva Bacterial Vaginosis Drug Product
Table 159. Teva Recent Development
Table 160. Perrigo Corporation Information
Table 161. Perrigo Description and Business Overview
Table 162. Perrigo Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Perrigo Bacterial Vaginosis Drug Product
Table 164. Perrigo Recent Development
Table 165. West-Ward Corporation Information
Table 166. West-Ward Description and Business Overview
Table 167. West-Ward Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. West-Ward Bacterial Vaginosis Drug Product
Table 169. West-Ward Recent Development
Table 170. HPGC Corporation Information
Table 171. HPGC Description and Business Overview
Table 172. HPGC Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. HPGC Bacterial Vaginosis Drug Product
Table 174. HPGC Recent Development
Table 175. Yunnan Baiyao Corporation Information
Table 176. Yunnan Baiyao Description and Business Overview
Table 177. Yunnan Baiyao Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Yunnan Baiyao Bacterial Vaginosis Drug Product
Table 179. Yunnan Baiyao Recent Development
Table 180. Starpharma Corporation Information
Table 181. Starpharma Description and Business Overview
Table 182. Starpharma Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. Starpharma Bacterial Vaginosis Drug Product
Table 184. Starpharma Recent Development
Table 185. Novel Corporation Information
Table 186. Novel Description and Business Overview
Table 187. Novel Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Novel Bacterial Vaginosis Drug Product
Table 189. Novel Recent Development
Table 190. Edenvridge Corporation Information
Table 191. Edenvridge Description and Business Overview
Table 192. Edenvridge Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 193. Edenvridge Bacterial Vaginosis Drug Product
Table 194. Edenvridge Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Bacterial Vaginosis Drug Distributors List
Table 198. Bacterial Vaginosis Drug Customers List
Table 199. Bacterial Vaginosis Drug Market Trends
Table 200. Bacterial Vaginosis Drug Market Drivers
Table 201. Bacterial Vaginosis Drug Market Challenges
Table 202. Bacterial Vaginosis Drug Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Bacterial Vaginosis Drug Product Picture
Figure 2. Global Bacterial Vaginosis Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bacterial Vaginosis Drug Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Bacterial Vaginosis Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Bacterial Vaginosis Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Bacterial Vaginosis Drug Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Bacterial Vaginosis Drug Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 13. Global Bacterial Vaginosis Drug Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Bacterial Vaginosis Drug Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Bacterial Vaginosis Drug Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Bacterial Vaginosis Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Bacterial Vaginosis Drug Players Market Share by Revenue in Bacterial Vaginosis Drug: 2016 & 2020
Figure 28. Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Bacterial Vaginosis Drug Revenue Share by Type (2016-2021)
Figure 30. Global Bacterial Vaginosis Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Bacterial Vaginosis Drug Revenue Share by Application (2016-2021)
Figure 32. Global Bacterial Vaginosis Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Bacterial Vaginosis Drug Sales Market Share by Type in 2020
Figure 34. North America Bacterial Vaginosis Drug Sales Market Share by Application in 2020
Figure 35. Europe Bacterial Vaginosis Drug Sales Market Share by Type in 2020
Figure 36. Europe Bacterial Vaginosis Drug Sales Market Share by Application in 2020
Figure 37. China Bacterial Vaginosis Drug Sales Market Share by Type in 2020
Figure 38. China Bacterial Vaginosis Drug Sales Market Share by Application in 2020
Figure 39. Japan Bacterial Vaginosis Drug Sales Market Share by Type in 2020
Figure 40. Japan Bacterial Vaginosis Drug Sales Market Share by Application in 2020
Figure 41. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Type in 2020
Figure 42. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Application in 2020
Figure 43. India Bacterial Vaginosis Drug Sales Market Share by Type in 2020
Figure 44. India Bacterial Vaginosis Drug Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Bacterial Vaginosis Drug
Figure 47. Manufacturing Process Analysis of Bacterial Vaginosis Drug
Figure 48. Bacterial Vaginosis Drug Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の細菌性膣炎治療市場規模・現状・予測（2021年-2027年） Bacterial vaginosis (BV) is a common vaginal infection.Is one of the most widely studied obstetric/gynecological infectious diseases.An infection associated with a group of pathogenic anaerobic microorganisms rather than a specific pathogen.This includes surgery and medication.Bacterial vaginosis is…- 世界の細菌性膣炎治療薬市場規模・現状・予測（2021年-2027年） Bacterial vaginosis is an infection characterised by overgrowth of anaerobic bacteria in the vagina with an accompanying loss of lactobacilli. Market Analysis and Insights: Global Bacterial Vaginosis Therapeutics Market The global Bacterial Vaginosis Therapeutics market size is projected to reach US…
- 世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年） Multidrug-resistant bacteria (MDROS), also known as multidrug-resistant microorganisms, are the result of bacterial variation and excessive use of antimicrobial agents. Market Analysis and Insights: Global Multiple Drug Resistance Bacterial Infection Treatment Market The global Multiple Drug Resista…
- 世界の水産養殖における細菌診断市場規模・現状・予測（2021年-2027年） At present aquaculture industries are one of the fastest growing industries in the globe. Unlike other livestock animals, aquatic animals also require proper attention in order to maintain their sound health. Careful deliberation required to select the rapid bacterial diagnostics in aquaculture meth…
- 微生物・細菌性セルロースのグローバル市場2021 Nanocellulose is a term referring to nano-structured cellulose. This may be either cellulose nanofibers (CNF), also called microfibrillated cellulose (MFC), nanocrystalline cellulose (NCC or CNC), or bacterial nanocellulose, which refers to nano-structured cellulose produced by bacteria. Nanocellulo…